Marius Marc-Daniel Mader1,2, Alan Napole1,2, Danwei Wu1,2,3

  • 1Institute for Stem Cell Biology and Regenerative Medicine and Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Nature neuroscience
|March 22, 2024
PubMed
概括

血造细胞移植 (HCT) 可以通过增加神经保护性髓状细胞来治疗多发性硬化症 (MS). 操纵这些髓状细胞为慢性中枢神经系统炎症性疾病提供了潜在的治疗方法.